Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Conatus Pharma Names Mason Yamashita VP, Pharmacovigilance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Conatus Pharma Names Mason Yamashita VP, Pharmacovigilance

Most recently served as VP of clinical development and drug safety at Isis Pharma

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Conatus Pharmaceuticals Inc., a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, appointed Mason Yamashita, vice president, Pharmacovigilance, reporting to David Hagerty, executive vice president, clinical development.

“We are pleased to welcome Mason to Conatus and to expand the capabilities of our clinical development team,” said Dr. Hagerty. “Mason brings a wealth of drug development and pharmacovigilance experience that strengthens our internal clinical development capabilities. His knowledge of clinical trial and regulatory reporting best practices and his successful record of building a pharmacovigilance function across a broad range of development programs provides an excellent background for leadership of this important function at Conatus. As Mason assumes responsibility for assessing and reporting on emricasan’s safety profile, we anticipate continued progress toward the initial registration of emricasan.”

Dr. Yamashita has been executive director and vice president of clinical development/drug safety since 2011 at Isis Pharmaceuticals.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics